Rabeprazole
Showing 1 - 25 of 272
Helicobacter Pylori Infection Trial in Chang chun (TNP-2198, Rabeprazole Sodium, Amoxicillin)
Completed
- Helicobacter Pylori Infection
- TNP-2198
- +2 more
-
Chang chun, Jilin, ChinaThe First Hospital of Jilin University
Oct 7, 2023
Helicobacter Pylori Infection Trial in Chang chun (TNP-2198, Rabeprazole Sodium, Amoxicillin)
Completed
- Helicobacter Pylori Infection
- TNP-2198
- +2 more
-
Chang chun, Jilin, ChinaThe First Hospital of Jilin University
Oct 7, 2023
Refractory Reflux Esophagitis Trial in Xi'an (Trimebutine Maleate, rabeprazole)
Withdrawn
- Refractory Reflux Esophagitis
- Trimebutine Maleate
- rabeprazole
-
Xi'an, Shaanxi, ChinaXijing Hosipital of Digestive Disease
Jan 30, 2023
Healthy Trial in Québec (Camlipixant + Rifampin, Camlipixant + Rabeprazole)
Not yet recruiting
- Healthy
- Camlipixant + Rifampin
- Camlipixant + Rabeprazole
-
Québec, Quebec, CanadaSyneos Health
Jun 2, 2023
Intrahepatic Cholangiocarcinoma Trial in Shanghai (HMPL-453, Rabeprazole)
Active, not recruiting
- Intrahepatic Cholangiocarcinoma
- HMPL-453
- Rabeprazole
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
Jun 24, 2023
Laryngopharyngeal Reflux Trial (Jinsang Liyan Capsule; Rabeprazole enteric-coated tablets., Jinsang Liyan Capsule ; Rabeprazole
Not yet recruiting
- Laryngopharyngeal Reflux
- Jinsang Liyan Capsule; Rabeprazole enteric-coated tablets.
- Jinsang Liyan Capsule placebo; Rabeprazole enteric-coated tablets.
- (no location specified)
May 26, 2023
H.Pylori Infection Trial in Beijing (Rifasutenizol capsules, Rabeprazole sodium enteric-coated tablets, Amoxicillin Capsules)
Not yet recruiting
- H.Pylori Infection
- Rifasutenizol capsules
- +7 more
-
Beijing, ChinaPeking University Third Hospital
May 3, 2023
The Eradication Rate of Helicobacter Pylori Trial (Vonopazan +Amoxicillin, Rabeprazole +colloidal pectin bismuth +Amoxicillin
Not yet recruiting
- The Eradication Rate of Helicobacter Pylori
- Vonopazan +Amoxicillin
- +3 more
- (no location specified)
Aug 21, 2023
Healthy Volunteers Trial in Tempe (Maribavir Commercial Tablet Formulation, Maribavir Pediatric Powder-for-oral Suspension
Not yet recruiting
- Healthy Volunteers
- Maribavir Commercial Tablet Formulation
- +2 more
-
Tempe, ArizonaCelerion
Jun 16, 2023
Drug-drug Interaction, Autoimmune Diseases, Fibrotic Disease Trial in Ruddington (Belumosudil, Itraconazole, Rabeprazole)
Completed
- Drug-drug Interaction
- +2 more
- Belumosudil
- +4 more
-
Ruddington, Nottingham, United KingdomQuotient Sciences Ltd
May 9, 2022
Healthy Trial in Biberach (BI 1810631 - trial formulation 1 (TF1), BI 1810631 - new formulation (NF), Rabeprazole sodium)
Completed
- Healthy
- BI 1810631 - trial formulation 1 (TF1)
- +2 more
-
Biberach, GermanyHumanpharmakologisches Zentrum Biberach
Sep 16, 2022
Relapsed or Refractory Lymphoma Trial in Miami (Itraconazole 200 mg, Fluconazole 400 mg, Rifampin 600 mg)
Completed
- Relapsed or Refractory Lymphoma
- Itraconazole 200 mg
- +3 more
-
Miami, FloridaQPS- Miami
Jan 12, 2023
Healthy Volunteers Trial in Baltimore (PC14586, Rabeprazole, Famotidine)
Not yet recruiting
- Healthy Volunteers
- PC14586
- +2 more
-
Baltimore, MarylandParexel International
Sep 19, 2023
Healthy Trial in Brussels (Sisunatovir, Rabeprazole)
Not yet recruiting
- Healthy
- Sisunatovir
- Rabeprazole
-
Brussels, Bruxelles-capitale, Région DE, BelgiumPfizer Clinical Research Unit - Brussels
Oct 24, 2023
Atrial Fibrillation, Venous Thromboembolism Trial in Hamilton (RABEprazole 20 Mg Oral Delayed Release Tablet, APO-Dabigatran
Completed
- Atrial Fibrillation
- Venous Thromboembolism
- RABEprazole 20 Mg Oral Delayed Release Tablet
- APO-Dabigatran 150mg
-
Hamilton, Ontario, CanadaThe Population Health Research Institute
Mar 18, 2022
Healthy Participants Trial (Single dose of PF-07220060 as first Tablet Formulation, Single dose of PF-07220060 as second Tablet
Not yet recruiting
- Healthy Participants
- Single dose of PF-07220060 as first Tablet Formulation
- +3 more
- (no location specified)
Jun 20, 2023
Healthy Volunteers Trial in Brooklyn (AZD5055 solution for infusion, AZD5055 oral suspension, AZD5055 film-coated tablet)
Recruiting
- Healthy Volunteers
- AZD5055 solution for infusion
- +3 more
-
Brooklyn, MarylandResearch Site
Dec 15, 2022
Helicobacter Pylori Infection Trial in Taipei (High-dose dual therapy (rabeprazole, amoxicillin), Bismuth High-dose dual therapy
Recruiting
- Helicobacter Pylori Infection
- High-dose dual therapy (rabeprazole, amoxicillin)
- +2 more
-
Taipei, TaiwanNational Taiwan University Hospital
Jan 18, 2022
Control of Bleed Trial (Proton Pump Inhibitors)
Not yet recruiting
- Control of Bleed
- Proton Pump Inhibitors
- (no location specified)
Nov 12, 2022
Healthy Participants Trial in Minato-ku (E7090, Rabeprazole 20 mg, Rifampin 600 mg)
Completed
- Healthy Participants
- E7090
- +2 more
-
Minato-ku, Tokoyo, JapanEisai trial site #1
Oct 29, 2021
Helicobacter Pylori Infection Trial in Kaohsiung (10d bismuth quadruple therapy, 14d hybrid therapy, 14D high-dose dual therapy)
Recruiting
- Helicobacter Pylori Infection
- 10d bismuth quadruple therapy
- +2 more
-
Kaohsiung, TaiwanKaohsiung Veterans General Hospital
Mar 11, 2022
Drug Interaction, Food-drug Interaction Trial in Cypress (fruquintinib with food/fruquintinib without food/fruquintinib with
Completed
- Drug Interaction
- Food-drug Interaction
- fruquintinib with food/fruquintinib without food/fruquintinib with rabeprazole
- fruquintinib without food/fruquintinib with food/fruquintinib with rabeprazole
-
Cypress, CaliforniaWCCT
Jun 16, 2021
Gastroesophageal Reflux Disease Trial in Seoul (AD-214-02, Rabeprazole)
Completed
- Gastroesophageal Reflux Disease
- AD-214-02
- Rabeprazole
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jul 20, 2021
Gastroesophageal Reflux Disease Trial in Seoul (Rabeprazole Sodium 10mg, Rabeprazole Sodium 20mg)
Recruiting
- Gastroesophageal Reflux Disease
- Rabeprazole Sodium 10mg
- Rabeprazole Sodium 20mg
-
Seoul, Daehak-ro Jongno-gu, Korea, Republic ofSeoul National University Hospital
Jun 25, 2021